Abstract
In this chapter we will focus on current laboratory methods to identify platelet function tests to identify the underlying (genetic) defect, allowing to apply the best possible treatment options. There are many reviews written on platelet function assays, especially on drug-induced defects or on drug monitoring, as used in many point-of-care applications [1–3]. Here, we will focus less on the methods underlying the distinct platelet function assays, but rather discuss methods to identify inherited thrombocytopathies.
References
O’Brien SH (2012) An update on pediatric bleeding disorders: bleeding scores, benign joint hypermobility, and platelet function testing in the evaluation of the child with bleeding symptoms. Am J Hematol 87(Suppl 1):S40–S44
Dovlatova N (2015) Current status and future prospects for platelet function testing in the diagnosis of inherited bleeding disorders. Br J Haematol 170(2):150–161
Gross L, Aradi D, Sibbing D (2016) Platelet function testing in patients on antiplatelet medications. Semin Thromb Hemost 17, Epub ahead of print
Andres O, Schulze H, Speer CP (2015) Platelets in neonates: central mediators in haemostasis, antimicrobial defence and inflammation. Thromb Haemost 113(1):3–12
Favaloro EJ, Lippi G, Franchini M (2010) Contemporary platelet function testing. Clin Chem Lab Med 48(5):579–598
Knofler R, Eberl W, Schulze H, Bakchoul T, Bergmann F, Gehrisch S et al (2014) Diagnosis of inherited diseases of platelet function. Interdisciplinary S2K guideline of the Permanent Paediatric Committee of the Society of Thrombosis and Haemostasis Research (GTH e. V.). Hamostaseologie 34(3):201–212
Jansen AJ, Josefsson EC, Rumjantseva V, Liu QP, Falet H, Bergmeier W et al (2012) Desialylation accelerates platelet clearance after refrigeration and initiates GPIbalpha metalloproteinase-mediated cleavage in mice. Blood 119(5):1263–1273
Hoffmeister KM (2011) The role of lectins and glycans in platelet clearance. J Thromb Haemost: JTH 9(Suppl 1):35–43
Schneppenheim R (2011) The pathophysiology of von Willebrand disease: therapeutic implications. Thromb Res 128(Suppl 1):S3–S7
von Lillicrap D (2013) Willebrand disease: advances in pathogenetic understanding, diagnosis, and therapy. Hematol/Educ Program Am Soc Hematol Am Soc Hematol Educ Program 2013:254–260
Marcus PD, Nire KG, Grooms L, Klima J, O’Brien SH (2011) The power of a standardized bleeding score in diagnosing paediatric type 1 von Willebrand’s disease and platelet function defects. Haemophilia: Off J World Fed Hemophilia 17(2):223–227
Robinson PN, Kohler S, Bauer S, Seelow D, Horn D, Mundlos S (2008) The Human Phenotype Ontology: a tool for annotating and analyzing human hereditary disease. Am J Hum Genet 83(5):610–615
Westbury SK, Turro E, Greene D, Lentaigne C, Kelly AM, Bariana TK et al (2015) Human phenotype ontology annotation and cluster analysis to unravel genetic defects in 707 cases with unexplained bleeding and platelet disorders. Genome Med 7(1):36
Briggs C, Harrison P, Machin SJ (2007) Continuing developments with the automated platelet count. Int J Lab Hematol 29(2):77–91
Nurden AT, Nurden P (2014) Congenital platelet disorders and understanding of platelet function. Br J Haematol 165(2):165–178
Quiroga T, Goycoolea M, Panes O, Aranda E, Martinez C, Belmont S et al (2007) High prevalence of bleeders of unknown cause among patients with inherited mucocutaneous bleeding. A prospective study of 280 patients and 299 controls. Haematologica 92(3):357–365
Pecci A, Noris P, Invernizzi R, Savoia A, Seri M, Ghiggeri GM et al (2002) Immunocytochemistry for the heavy chain of the non-muscle myosin IIA as a diagnostic tool for MYH9-related disorders. Br J Haematol 117(1):164–167
Navarro-Nunez L, Teruel R, Anton AI, Nurden P, Martinez-Martinez I, Lozano ML et al (2011) Rare homozygous status of P43 beta1-tubulin polymorphism causes alterations in platelet ultrastructure. Thromb Haemost 105(5):855–863
Cattaneo M, Cerletti C, Harrison P, Hayward CP, Kenny D, Nugent D, et al (2013) Recommendations for the standardization of light transmission aggregometry: a consensus of the working party from the Platelet Physiology Subcommittee of SSC/ISTH. J Thromb Haemost: JTH Journal of Thrombosis and Haemostasis 11(6):1183–1189
McGlasson DL, Fritsma GA (2009) Whole blood platelet aggregometry and platelet function testing. Semin Thromb Hemost 35(2):168–180
Peerschke EI, Castellone DD, Stroobants AK, Francis J (2014) Reference range determination for whole-blood platelet aggregation using the Multiplate analyzer. Am J Clin Pathol 142(5):647–656
Pai M, Wang G, Moffat KA, Liu Y, Seecharan J, Webert K et al (2011) Diagnostic usefulness of a lumi-aggregometer adenosine triphosphate release assay for the assessment of platelet function disorders. Am J Clin Pathol 136(3):350–358
Cattaneo M (2009) Light transmission aggregometry and ATP release for the diagnostic assessment of platelet function. Semin Thromb Hemost 35(2):158–167
Cattaneo M, Hayward CP, Moffat KA, Pugliano MT, Liu Y, Michelson AD (2009) Results of a worldwide survey on the assessment of platelet function by light transmission aggregometry: a report from the platelet physiology subcommittee of the SSC of the ISTH. J Thromb Haemost: JTH 7(6):1029
Israels SJ, Kahr WH, Blanchette VS, Luban NL, Rivard GE, Rand ML (2011) Platelet disorders in children: a diagnostic approach. Pediatr Blood Cancer 56(6):975–983
Gresele P, Subcommittee on Platelet Physiology of the International Society on T, Hemostasis (2015) Diagnosis of inherited platelet function disorders: guidance from the SSC of the ISTH. J Thromb Haemost: JTH 13(2):314–322
Bakchoul T, Zollner H, Greinacher A (2014) Current insights into the laboratory diagnosis of HIT. Int J Lab Hematol 36(3):296–305
Prechel M, Hilby AM, Walenga JM (2008) Cross reactivity of heparin-induced PF4 antibodies with heparin-bound IL-8. Blood 112(11):3429
Althaus K, Hron G, Strobel U, Abbate R, Rogolino A, Davidson S, et al (2013)_ Evaluation of automated immunoassays in the diagnosis of heparin induced thrombocytopenia. Thromb Res 131(3):e85–e90
Arepally G, Reynolds C, Tomaski A, Amiral J, Jawad A, Poncz M et al (1995) Comparison of PF4/heparin ELISA assay with the 14C-serotonin release assay in the diagnosis of heparin-induced thrombocytopenia. Am J Clin Pathol 104(6):648–654
Bakchoul T, Giptner A, Bein G, Santoso S, Sachs UJ (2011) Performance characteristics of two commercially available IgG-specific immunoassays in the assessment of heparin-induced thrombocytopenia (HIT). Thromb Res 127(4):345–348
Bakchoul T, Giptner A, Najaoui A, Bein G, Santoso S, Sachs UJ (2009) Prospective evaluation of PF4/heparin immunoassays for the diagnosis of heparin-induced thrombocytopenia. J Thromb Haemost 7(8):1260–1265
Lindhoff-Last E, Gerdsen F, Ackermann H, Bauersachs R (2001) Determination of heparin-platelet factor 4-IgG antibodies improves diagnosis of heparin-induced thrombocytopenia. Br J Haematol 113(4):886–890
Pouplard C, Gueret P, Fouassier M, Ternisien C, Trossaert M, Regina S et al (2007) Prospective evaluation of the ‘4Ts’ score and particle gel immunoassay specific to heparin/PF4 for the diagnosis of heparin-induced thrombocytopenia. J Thromb Haemost 5(7):1373–1379
Sachs UJ, von HJ, Santoso S, Bein G, Bakchoul T (2011) Evaluation of a new nanoparticle-based lateral-flow immunoassay for the exclusion of heparin-induced thrombocytopenia (HIT). Thromb Haemost 106(6):1197–11202
Whitlatch NL, Kong DF, Metjian AD, Arepally GM, Ortel TL (2010) Validation of the high-dose heparin confirmatory step for the diagnosis of heparin-induced thrombocytopenia. Blood 116(10):1761–1766
Whitlatch NL, Perry SL, Ortel TL (2008) Anti-heparin/platelet factor 4 antibody optical density values and the confirmatory procedure in the diagnosis of heparin-induced thrombocytopenia. Thromb Haemost 100(4):678–684
Greinacher A, Michels I, Kiefel V, Mueller-Eckhardt C (1991) A rapid and sensitive test for diagnosing heparin-associated thrombocytopenia. Thromb Haemost 66(6):734–736
Sheridan D, Carter C, Kelton JG (1986) A diagnostic test for heparin-induced thrombocytopenia. Blood 67(1):27–30
Consortium UK, Walter K, Min JL, Huang J, Crooks L, Memari Y et al (2015) The UK10K project identifies rare variants in health and disease. Nature 526(7571):82–90
Gieger C, Radhakrishnan A, Cvejic A, Tang W, Porcu E, Pistis G et al (2011) New gene functions in megakaryopoiesis and platelet formation. Nature 480(7376):201–208
Noris P, Perrotta S, Seri M, Pecci A, Gnan C, Loffredo G et al (2011) Mutations in ANKRD26 are responsible for a frequent form of inherited thrombocytopenia: analysis of 78 patients from 21 families. Blood 117(24):6673–6680
Noetzli L, Lo RW, Lee-Sherick AB, Callaghan M, Noris P, Savoia A et al (2015) Germline mutations in ETV6 are associated with thrombocytopenia, red cell macrocytosis and predisposition to lymphoblastic leukemia. Nat Genet 47(5):535–538
Jongmans MC, Kuiper RP, Carmichael CL, Wilkins EJ, Dors N, Carmagnac A et al (2010) Novel RUNX1 mutations in familial platelet disorder with enhanced risk for acute myeloid leukemia: clues for improved identification of the FPD/AML syndrome. Leukemia 24(1):242–246
Buitrago L, Rendon A, Liang Y, Simeoni I, Negri A, ThromboGenomics C et al (2015) alphaIIbbeta3 variants defined by next-generation sequencing: predicting variants likely to cause Glanzmann thrombasthenia. Proc Natl Acad Sci U S A 112(15):E1898–E1907
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Bakchoul, T., Schulze, H. (2016). Diagnosis of Inherited and Acquired Platelet Disorders. In: Schulze, H., Italiano, J. (eds) Molecular and Cellular Biology of Platelet Formation. Springer, Cham. https://doi.org/10.1007/978-3-319-39562-3_17
Download citation
DOI: https://doi.org/10.1007/978-3-319-39562-3_17
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-39560-9
Online ISBN: 978-3-319-39562-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)